PULMATRIX, INC.
Profile
Company Names
PULMATRIX, INC.
RUTHIGEN, INC.
Addresses
945 CONCORD STREET, SUITE 1217, FRAMINGHAM, MA 01701
99 HAYDEN AVENUE, SUITE 390, LEXINGTON, MA 02421
99 HAYDEN AVENUE, SUITE 390, LEXINGTON, MA 02421
2455 BENNETT VALLEY RD. SUITE C116, SANTA ROSA, CA 95404
Phone Numbers
(888) 355-4440
781-357-2333
(781) 357-2333
(707) 525-9900
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, PHARMACEUTICALS
Year Incorporated:
2013
State Incorporated:
DELAWARE
Total Amount Raised:
$18,652,665.00
Number of Funding Rounds:
10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2026-03-26
$1,000,000.00
$1,000,000.00
$0.00
Equity
9
2021-02-16
$0.00
$3,250,000.00
$3,250,000.00
8
2020-07-09
$45,000.00
$19,629,373.00
$19,584,373.00
7
2020-04-16
$8,070,723.00
$8,070,723.00
$0.00
6
2019-02-12
$2,489,820.00
$2,489,820.00
$0.00
5
2019-02-04
$73,531.00
$73,531.00
$0.00
4
2019-01-31
$21,565.00
$21,565.00
$0.00
3
2018-12-03
$3,656,250.00
$3,656,250.00
$0.00
2
2015-06-15
$687,500.00
$687,500.00
$0.00
Equity
1
2015-06-01
$2,608,276.00
$2,608,526.00
$250.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
HOJABR
ALIMI
EXECUTIVE OFFICER, PROMOTER
ROBERT
CLARKE
EXECUTIVE OFFICER, DIRECTOR
RICHARD
CONLEY
DIRECTOR, PROMOTER
STEVEN
GILLIS
DIRECTOR
TRUBION PHARMACEUTICALS, INC
| PHASERX INC
| PULMATRIX INC
| THERACLONE SCIENCES, INC.
| MIRINA CORP
| SURFACE LOGIX INC
| ACYLIN THERAPEUTICS, INC.
| BLUEBIRD BIO, INC.
| VARIATION BIOTECHNOLOGIES (US), INC.
| GROOVE BIOPHARMA CORP
| ALLOZYNE INC
| PHASERX, INC.
| VIRAL LOGIC SYSTEMS TECHNOLOGY CORP
| FARADAY PHARMACEUTICALS, INC.
| PULMATRIX OPERATING COMPANY, INC.
| LYCERA CORP
| PULMATRIX, INC.
| NEXGENIA INC.
| CODIAK BIOSCIENCES, INC.
| VBI VACCINES INC/BC
| NOHLA THERAPEUTICS INC.
| HOMOLOGY MEDICINES, INC.
| IMMUSANT, INC.
| ONCORESPONSE INC
| EGENESIS, INC.
| ARCH VENTURE FUND X, L.P.
| ARCH VENTURE FUND X OVERAGE, L.P.
| ARCH VENTURE FUND XI, L.P.
| HC BIOSCIENCE, INC.
| ARCH VENTURE FUND XII, L.P.
| PHEAST THERAPEUTICS, INC.
| SONOTHERA, INC.
| PRONIRAS CORP
| ONCORESPONSE, INC
KURT
GRAVES
DIRECTOR
SAMEER
HARISH
EXECUTIVE OFFICER, PROMOTER
MICHAEL
HIGGINS
DIRECTOR
MICHAEL
J.
HIGGINS
DIRECTOR
MARK
IWICKI
DIRECTOR
PETER
LUDLUM
EXECUTIVE OFFICER
DAVID
MAKI
DIRECTOR
PULMATRIX INC
| PULMATRIX OPERATING COMPANY, INC.
| PULMATRIX, INC.
| ALTITUDE LIFE SCIENCE VENTURES SIDE FUND II, L.P.
| EFFECTOR THERAPEUTICS, INC.
| HDP I REIT LLC
| HEITMAN CORE REAL ESTATE DEBT INCOME TRUST, L.P.
| HEITMAN CREDIT REIT, LLC
| ALTITUDE LIFE SCIENCE VENTURES SIDE FUND III, L.P.
| APFC HCF HOLDINGS REIT LLC
| HEITMAN GLOBAL REAL ESTATE REIT LLC
| HEITMAN REAL ESTATE DEBT PARTNERS III, L.P.
| HEITMAN REAL ESTATE DEBT PARTNERS III-A, L.P.
| HEITMAN REAL ESTATE DEBT PARTNERS III-BLOCKER, L.P.
| HDP III REIT INVESTMENTS LLC
TERRANCE
MCGUIRE
DIRECTOR
MICROCHIPS, INC.
| ARSENAL MEDICAL, INC.
| ADIMAB, INC.
| ARSANIS, INC.
| ARSENAL VASCULAR, INC.
| ARSENAL MEDICAL, INC.
| ADIMAB, LLC
| 480 BIOMEDICAL, INC.
| POLARIS ENTREPRENEURS- FUND VII, L.P.
| PULMATRIX OPERATING COMPANY, INC.
| PULMATRIX, INC.
| ICELANDIC PROVISIONS, INC.
| SEER BIOSCIENCES, INC.
| CYCLERION THERAPEUTICS, INC.
| ANKYRA THERAPEUTICS, INC.
| ADAGIO THERAPEUTICS, INC.
| FARADAY PHARMACEUTICALS, INC.
| TECTONIC THERAPEUTIC, INC.
AMIT
MUNSHI
DIRECTOR
SCOTT
ROCKLAGE
DIRECTOR
RENNOVIA INC
| PULMATRIX INC
| 5AM CO-INVESTORS III, L.P.
| ACHAOGEN INC
| RELYPSA INC
| WAVERX INC
| SEMPRUS BIOSCIENCES CORP
| VARIATION BIOTECHNOLOGIES (US), INC.
| KINESTRAL TECHNOLOGIES, INC.
| NOVIRA THERAPEUTICS, INC.
| 5AM CO-INVESTORS IV, L.P.
| K2 THERAPEUTICS, INC.
| CIDARA THERAPEUTICS, INC.
| PULMATRIX OPERATING COMPANY, INC.
| PULMATRIX, INC.
| EXPANSION THERAPEUTICS, INC.
| ALBAMUNITY, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2026-03-26
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2015-06-15
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2015-06-15
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2015-06-15
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2015-06-01

